Coronel CC

Language: Spanish
References: 29
Page: 61-65
PDF size: 57.59 Kb.

ABSTRACT

Objective. To compare the effectiveness of the cromolyn sodium-salbutamol in the prevention of asthma crisis due to acute respiratory tract infections.
Material and methods. Case-control study in 410 asthmatic children below than five years age were divided in a group of cases (219) treated with salbutamol and cromoly sodium and a control group (195) with beclomethasone.
Results. 70.6% of the cases group had 2.5/year crisis, while 54.3% of the control group had 3.2 crisis by year. The average duration of the crisis in the study group was of 50.7 hours and 58.6 hours in the control group. The asthma crisis were mild in 68.3% of children that received cromoly sodium and salbutamol, and in 61.6% of the those treated with beclomethasone. The 8.4% of the children of the group study and 12.2 of the controls were admitted in the hospital. Asthma crisis was presented each 1.8 episode of respiratory tract infection in the children of the group of cases and each 1.3 those in the control group.
Conclusions. The cromoly sodium-salbutamol seem to be a good option in the prevention of crisis of asthma exacerbation due to respiratory tract infections in the children below five years age.

REFERENCES

1. Asociación Mexicana de Pediatría. Segundo Consenso Mexicano de Asma en Pediatría. Acta Pediatr Mex 2002; 23(Supl 1): 1-39.

2. Irani AM. The challenge of mild persistent asthma. Ann Allergy Asthma Immunol 2005; 94(5): 517-27.

3. Rojo M. Asma bronquial. En: De la Torre E, González JA, Gutiérrez JA, Jordán J, Pelayo EJ. Neumología. Pediatría. Editorial Ciencias Médicas: Ciudad de la Habana; 2005: 111-46.

4. Kabra SK, Lodha R. Long-term management of asthma. Indian J Pediatr 2003; 70(1): 63-72.

5. Coronel C. Crisis de asma según factores desencadenantes. Rev Mex Pediatr 2006; 73(3): 107-11.

6. Levy J, Zalkinder I, Kuperman O, Skibin A, Apte R, Bearman J et al. Effect of prolonged use of inhaled steroids on the cellular immunity of children with asthma. J Allergy Clin Immunol 1995; 95(4): 806-12.

7. Kannisto S, Korppi M, Remes K, Voutilainen R. Adrenal suppression evaluated by a low dose adrenocorticocotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab 2000; 85(2): 652-7.

8. Couturier J, Steele M, Hussey L, Pawliuk G. Steroid-induced mania in an adolescent: risk factors and management. Can J Clin Pharmacol 2001; 8(2): 109-12.

9. Todd G. La crisis de insuficiencia suprarrenal asociada con la inhalación de corticoides. Arch Dis Child 2002; 87: 457-61.

10. Kato Y, Muraki K, Fujitaka M, Sakuva N, Ueda K. Disodium cromoglycate use in children and adolescents with asthma: correlation between plasma concentrations and protective effects for various inhalation methods. Ann Allergy Immunol 1999; 83(6): 553-8.

11. Kato Y, Muraki K, Fujitaka M, Sakura N, Ueda K. Plasma concentrations of disodium cromoglycate after various inhalations methods in healthy subjects. Br J Clin Pharmacol 1999; 48(2): 154-7.

12. Nerbrink OL, Lindstrom M, Meurling L, Svartengren M. Inhalation and deposition of nebulized sodium cromoglycate in two different particle size distributions in children with asthma. Pediatr Pulmonol 2002; 34(5): 351-60.

13. Yamaguchi H, Oosika E, Nakano H, Kaneko I, Nakayama T, Mitubayashi K, Siigai N, Okada F, Mitubayashi T, Sasaki N, Suzuki I, Akasaka T. The effect of particle size and amount of inhalation on the pulmonary function tests in asthmatic children. Arerugi 2004; 53(11): 1152-62.

14. Anderson SD. Single-dose agents in the prevention of exercise-induced asthma: a descriptive review. Treat Respir Med 2004; 3(6): 365-79.

15. Hidari KI, Tsujii E, Hiroi J, Mano E, Miyatake A, Miyamoto D, Suzuki T, Suzuki Y. In vitro and in vivo inhibitory effects of disodium cromoglycate on influenza virus infection. Biol Pharm Bull 2004; 27(6): 825-30.

16. Sly M. Trastornos alérgicos. En: Behrman RE, Kliegma RM, Arvin AM. Nelson. Tratado de Pediatría. 15ª Ed. Ciudad de la Habana: Editorial de Ciencias Médicas; 1998: 765-802.

17. Mencol E, Drovet M, Sabat A. Membrane stabilizers. Allerg Immunol 1999; 3(4): 103-5.

18. Nabe T, Yamamoto M, Suga M, Kohno S. Intratracheal dosing with disodium cromoglycate inhibits late asthmatic response by attenuating eicosanoid production in Guinea pigs. Eur J Pharmacol 2004; 497(1): 97-104.

19. Koyama H, Tokuyama K, Nishimura H, Mizuno T, Mayuzumi H, Ohki Y, Arakawa H, Mochizuki H, Morikawa A. Effect of disodium cromoglycate on airway mucus secretion during antigen-induced late asthmatic responses in a murine model of asthma. Int Arch Allergy Immunol 2005; 138(3): 189-96.

20. Blake K, Kamada AK. Asthma. In: Herfindal ET, Gourley DR. Textbook of therapeutics drugs and disease management. Pennsylvania: Williams and Wilkins 1996: 651-84.

21. Serafín WE. Fármacos utilizados para el tratamiento del asma. En: Hardman JG, Limbird LE, Goodman A. Las bases farmacológicas de la terapéutica. Goodman and Gilman. México: McGraw-Hill Interamericana; 1996: 707-31.

22. Furukawa C, Atkinson D, Forster JJ, Nazario K, Simpson B, Uriniack T et al. Controlled trial of two formulations of cromoglyn sodium in the treatment of asthmatic patients. Chest 1999; 116(1): 65-72.

23. Matsuo N, Shimoda T, Matsuse H, Obase Y, Asai S, Khono S. Effects of sodium cromoglycate on cytokine production following antigen stimulation of a passively sensitized human lung model. Ann Allergy Asthma Immunol 2000; 84(1): 72-8.

24. Jahnova E, Harvatova M, Gazdik F. Expression of adhesion molecules and effect of sodium cromoglycate treatment in asthmatics. Physiol Resp 1998; 47(6): 439-43.

25. Harvathova M, Podivinsky F, Gazdik F, Jahnova E. Effect of disodium cromoglycate treatment on peripheral blood mononuclear cell adhesion to cultured endothelium in allergic, asthmatic. Physiol Resp 1998; 47(6): 445-51.

26. Matsuse H, Matsuo N, Shimoda T, Obase Y, Asai S, Khono S et al. Sodium cromoglycate inhibits antigen induced cytokine production by peripheral blood mononuclear cells from atopic asthmatic in vitro. Ann Allergy Asthma Immunol 1999; 83(6): 511-5.

27. Cáceres A, Hernández M, Muñoz J, Rodríguez A. Las vitaminas en la nutrición humana. Las Palmas de Gran Canaria: Editorial Romero; 1999.

28. Expert Panel Report 2: Guidelines for the diagnosis a management of asthma. Bethesda (MD): National Asthma Education and Prevention Program, National Institutes of Health; 1997. Report No.: NHI-97-4051 A.

29. Morón FJ, Levy M. Farmacología General. La Habana: Editorial Ciencias Médicas; 2002.